As long as Schwab, Zack and the likes continue to rate ATRS as a strong sell share price most likely will continue to be unpredictable. I doubt if they base their recommendation on the future of this company but only what the share price will be tomorrow morning. With what we know about the company the share price today is a bargain and the future bright.
"With what we know about the company the share price today is a bargan and the future is bright."
The key is "what we know."
Management --- I've seen many management teams take a lot, and produce little. I've seen some managements teams take a little, and produce a lot. I believe The ATRS management team belongs in the group that has to date, produced a lot.
Business model---An excellent drug delivery system using FDA approved drugs. Low risk and potential high reward. Partnerships with major pharma. A good pipeline. In house drug developement, which could tranform the company. Good balance sheet. Cash in bank and a well managed small burn rate. Increase in revenues and future increases looking bright.
Patents--- I personally do not put much emphasis on patent "applications". It is a long journey from a patent application, to management deciding to spend money for developement, to FDA approval. My point is I depend on the company to inform if they intend to pursue developement, or partnership, of a patent. Then it becomes a fact, something to look forward to in assessing my overall view of company product developement. Just my personal take and view regarding patent applications.
I concede none of this post is news to any serious investor in ATRS. I was attempting to contrast facts we know, from speculation. I'm sure I missed many points. There are other contributors on this message who can frame a message better than myself, and comments are welcome. But I agree with sarab80200, the future is bright with what we know.
"I doubt if they base their recommendation on the future of this company"
They don't - - You can count on it !!!!!
I don't know on what they base their recommendations - Schwab is
presumed to be legitimate with their research, maybe not-
As for Zack - I haven't a clue as to what motivates them.
Some years ago, in the tech boom, a Merrill analyst was about the worst
offender - being on the phone screaming "buy" to clients when with the other
hand he was hitting the sell button on his computer.
One analyst, (some might remember- Joe Granville) who gave speeches from
a coffin and predicted the demise of the markets (and sometimes the world)-
Where is he now ? Who knows and who cares.
Many such frauds and clowns inhabit the investment world with all sorts of
(I had an uncle, a great showman who owned a circus. He always wanted to be
perceived as a winner. He would go to the racetrack with friends and secretly
buy a ticket on every horse in the race. He had a system. He would put the 1
horse ticket in his hat. 2 in his shirt pocket. 3 in his right pants pocket, etc.
And when the race was over he would reach into the appropriate pocket and
announce - Another Winner).
POINT IS - I wouldn't be surprised if Zack has a sister company that was
recommending a strong buy on ATRS - so they could claim they were right
either way the stock moved.
BUT - This is all nonsense. We have extremely reputable institutions owing
over 40% of our shares. We have respected analysts covering with a buy.
We have acknowledged one of the strongest pipeline in small pharma and a
management team capable of making it all work. We have $88 million in the
bank, no debt, and a very small burn (by choice, as we are investing in R & D
for a much stronger tomorrow)..
There are some stock picking touts that are so disreputable that for them to
say "buy" - is almost like a curse. Like a lawyer, known to represent the worst
criminals in society; His representations is almost a sure indication that the
defendant is most probably guilty.
That said - I have little respect for Zack - Schwab is, for the most part, a
respected company (while I give them zero points for credibility when they
bash ATRS) - I would rather they said good things about us than bad
things; and they can hurt us by a few pennies in the short term.
BUT I would never buy another stock, never make another investment, surely
never make recommendations to friends - if I didn't have the courage of my
convictions and the confidence in my research and network of friends - to
make decisions that I am comfortable are based on excellent due diligence
and a recognition of FACTS.
whether you rate ATRS buy or sell at the moment has a lot to do how one looks at an investment opportunity, for those who primarily focus on small downward risk and are willing to lock up their cash for at least next 24-months then ATRS is a buy and accumulate stock at these prices, and for those who are hunting for the next "hot" bio-stock with 2x-3x upside in the next 6-12 months then for such investors ATRS maybe is a sell, however I still think selling at 3.80s is just dumb..if I wanted to get out of this stock I would at least wait for the next swing up into 4s...